Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Spinal Cord Injuries

In brief

The objective of the proposed study is to conduct the first ever prospective, dose-exploration trial to test the feasibility of early administration of gabapentin as an intervention for neurorecovery. This research project falls under the Intervention Development stage of research as the primary goal is to assess the feasibility of conducting a well-designed intervention efficacy study in the future.

Key facts

Study ID

NCT05302999

Run by

MetroHealth Medical Center

People needed

42

Starts

2022-03-14

Expected to finish

2026-08-31

Last updated by the study team

2025-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Traumatic SCI;
• All levels of SCI;
• All severities of SCI, AIS A-D;
• Age 18 years and older.
• Agree to participate and start study drug within 120 hours' post-injury.
• Adequate cognition and communication to provide informed consent

You may not qualify if…

• Presence of moderate/severe traumatic brain injury (TBI) as defined by Glasgow Coma Score (GCS) < 13 at 120 hours' post-injury.
• Documented use of gabapentinoids at the time of injury.

Where it is running

• MetroHealth Medical Center — Cleveland, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.